VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were down 6.1% on Wednesday . The company traded as low as C$0.16 and last traded at C$0.16. Approximately 16,500 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 263,513 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 6.3 %
The firm’s 50 day simple moving average is C$0.13 and its 200-day simple moving average is C$0.13. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The company has a market cap of C$24.33 million, a price-to-earnings ratio of -4.63 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Recommended Stories
- Five stocks we like better than VentriPoint Diagnostics
- High Flyers: 3 Natural Gas Stocks for March 2022
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Invest in the Best Canadian Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Comparing and Trading High PE Ratio Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
